Combination treatment of withalongolide a triacetate with cisplatin induces apoptosis by targeting translational initiation, migration, and epithelial to mesenchymal transition in head and neck squamous cell carcinoma

HIGHLIGHTS

  • who: Chitra Subramanian and colleagues from the Departments of Surgery and Bioengineering, Carle Illinois College of Medicine, University of Illinois, Urbana-Champaign, IL, USA have published the research: Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma, in the Journal: Nutrients 2022, 14, x FOR PEER REVIEW of 16/Nov/2022
  • what: The authors evaluate treatment responses including cell viability, cellular proliferation, epithelial to mesenchymal transition (EMT), apoptosis, cellular pathways classically implicated in carcinogenesis and cisplatin resistance . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?